Navigation Links
Axial Biotech appoints new Vice President of Strategic Initiatives
Date:9/5/2008

Industry Veteran is Well-Positioned to Expand Business Development Efforts

SALT LAKE CITY, Sept. 5 /PRNewswire/ -- Axial Biotech Inc., a company focused on the development of molecular diagnostic and motion preserving technologies in the spine care market, announced today that Joe Ross has joined the executive management team as the company's new Vice President of Strategic Initiatives.

In this new role, Ross will oversee Axial Biotech's global efforts to identify, evaluate, and pursue new diagnostic opportunities and will help to coordinate the company's long-term business strategy, solicit investment backing, and expand key development partnerships.

John Climaco, President and CEO of Axial Biotech, stated, "As we prepare for the commercial introduction of our DNA based prognostic test for Adolescent Idiopathic Scoliosis with our partners at DePuy Spine, we look forward to building on our successful research, and developing additional diagnostic tools to meet the clinical needs of today, and those anticipated in the future. Mr. Ross is uniquely qualified to drive this effort given his vast industry knowledge and experience, and successful track record of working closely with physician thought leaders to develop innovative clinical solutions."

Ross brings with him more than 12 years of experience in orthopedic medical devices and biologics. Prior to his most recent position as Vice President of Global Marketing for Stryker Biotech, Ross worked 11 years with the DePuy Spine division of Johnson and Johnson Corporation in roles of increasing responsibility including Worldwide Vice President for New Business Development. Ross has led numerous successful product and business development efforts and has been granted multiple U.S. patents. He is a graduate of the University of Notre Dame and Troy State University. He has also served five years as an officer in the United States Navy.

"I am thrilled to be joining the Axial Biotech team of accomplished researchers, clinicians and business professionals," said Ross. "The technologies being developed by Axial Biotech have the potential to transform not only the diagnostic process, but the identification and timing of the appropriate therapy, and ultimately to drive the development of revolutionary new treatments for multiple diseases of the spine. This is transformational technology that will significantly enhance patient outcomes and quality of life."

About Axial Biotech

Axial Biotech, Inc. develops molecular diagnostic assays and motion preservation technologies for common spinal diseases and disorders. Axial has developed the first DNA based prognostic test for Adolescent Idiopathic Scoliosis. Axial is accredited by the College of American Pathologists (CAP) and is certified to comply with the Clinical Laboratory Improvement Amendments (CLIA). Founded in 2002, Axial is based in Salt Lake City, Utah.


'/>"/>
SOURCE Axial Biotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
2. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
3. BioMarin to Present at the Citi Biotech Day
4. /R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/
5. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
6. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
7. Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes
8. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
11. BioSpace and BayBio announce 2008-2009 Biotech Bay(TM) Hotbed Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... Founder of ... board-certified in surgery and surgery of the hand by the National Board of ... to going above and beyond in his pursuit of providing the most comprehensive, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Lady had been battling arthritis ... cruciate ligament in her left knee. Lady’s owner Hannah sought the help of Dr ... veterinary surgeon, to repair her cruciate ligament and help with the pain of Lady’s ...
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, an integrated ... entrepreneurs, held The Future of San Diego Life Science event at the Estancia La ... community attended the event with speakers Dr. Rich Heyman, former CEO of Aragon and ...
(Date:5/23/2016)... 2016 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... its Board of Directors has approved the payment of a ... 2016. The cash dividend of $0.24 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
Breaking Biology Technology:
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
(Date:3/18/2016)... , March 18, 2016 --> ... of Biometrics, ICT, Manned & Unmanned Vehicles, Physical infrastructure and ... security companies in the border security market and the continuing ... and Europe has led visiongain to ... improved success. --> defence & security companies ...
(Date:3/15/2016)... , March 15, 2016 Yissum ... , the technology-transfer company of the Hebrew University, announced ... of remote sensing technology of various human biological indicators. ... raising $2.0 million from private investors. ... based on the detection of electromagnetic emissions from sweat ...
Breaking Biology News(10 mins):